Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Huber

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Zeitschrift Fur Gastroenterologie|April 21, 2017
Michael P Manns, Petra Huber, Elmar Jaeckel
Skin Pharmacology and Physiology|January 20, 2025
How to Choose an Emollient? Pharmaceutical and Sensory Attributes for Product SelectionPetra Huber, Daphne Reinau, Zoé Brodard, et al.
Expert Opinion on Pharmacotherapy|April 17, 2025
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugatesMatthias Ocker, Christian Mayr, Petra Huber-Cantonati, et al.
Deutsches Arzteblatt International|July 15, 2014
In replyNisar P Malek, Sebastian Schmidt, Petra Huber, et al.
Deutsches Arzteblatt International|March 14, 2014
The diagnosis and treatment of hepatocellular carcinomaNisar P Malek, Sebastian Schmidt, Petra Huber, et al.
Antioxidants (Basel, Switzerland)|January 8, 2025
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy-A State-of-the-Art ReviewOlaf Rose, Tim Croonenberg, Stephanie Clemens, et al.
Biochemical Pharmacology|June 7, 2024
Impact of 2-hydroxypropyl-β-cyclodextrin inclusion complex formation on dopamine receptor-ligand interaction - A case studyLukas Zell, Thomas S Hofer, Mario Schubert, et al.
Chemistry & Biology|March 7, 2002
Glycopeptide biosynthesis in Amycolatopsis mediterranei DSM5908: function of a halogenase and a haloperoxidase/perhydrolaseOliver Puk, Petra Huber, Daniel Bischoff, et al.
Chemistry & Biodiversity|February 18, 2025
Prenylated Chalcones From Roots of Kidney Vetch (Anthyllis vulneraria L.) With Antiproliferative ActivityPeter Lorenz, Jürgen Conrad, Iris Klaiber, et al.
Cancer Biology & Therapy|December 13, 2024
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancerCelina Ablinger, Daniel Neureiter, Theresa Mähr, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Gastroenterologie|April 21, 2017
Michael P Manns, Petra Huber, Elmar Jaeckel
Skin Pharmacology and Physiology|January 20, 2025
How to Choose an Emollient? Pharmaceutical and Sensory Attributes for Product SelectionPetra Huber, Daphne Reinau, Zoé Brodard, et al.
Expert Opinion on Pharmacotherapy|April 17, 2025
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugatesMatthias Ocker, Christian Mayr, Petra Huber-Cantonati, et al.
Deutsches Arzteblatt International|July 15, 2014
In replyNisar P Malek, Sebastian Schmidt, Petra Huber, et al.
Deutsches Arzteblatt International|March 14, 2014
The diagnosis and treatment of hepatocellular carcinomaNisar P Malek, Sebastian Schmidt, Petra Huber, et al.
Antioxidants (Basel, Switzerland)|January 8, 2025
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy-A State-of-the-Art ReviewOlaf Rose, Tim Croonenberg, Stephanie Clemens, et al.
Biochemical Pharmacology|June 7, 2024
Impact of 2-hydroxypropyl-β-cyclodextrin inclusion complex formation on dopamine receptor-ligand interaction - A case studyLukas Zell, Thomas S Hofer, Mario Schubert, et al.
Chemistry & Biology|March 7, 2002
Glycopeptide biosynthesis in Amycolatopsis mediterranei DSM5908: function of a halogenase and a haloperoxidase/perhydrolaseOliver Puk, Petra Huber, Daniel Bischoff, et al.
Chemistry & Biodiversity|February 18, 2025
Prenylated Chalcones From Roots of Kidney Vetch (Anthyllis vulneraria L.) With Antiproliferative ActivityPeter Lorenz, Jürgen Conrad, Iris Klaiber, et al.
Cancer Biology & Therapy|December 13, 2024
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancerCelina Ablinger, Daniel Neureiter, Theresa Mähr, et al.
Pageof 2